Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Harvard Business School

Generated: October 20, 2017

DrugPatentWatch Database Preview

AMICAR Drug Profile

« Back to Dashboard

What is the patent landscape for Amicar, and when can generic versions of Amicar launch?

Amicar is a drug marketed by Clover Pharms and is included in three NDAs.

The generic ingredient in AMICAR is aminocaproic acid. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aminocaproic acid profile page.

Summary for Tradename: AMICAR

US Patents:0
Suppliers / Packagers: see list3
Bulk Api Vendors: see list89
Clinical Trials: see list9
Patent Applications: see list7,941
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMICAR at DailyMed

Pharmacology for Tradename: AMICAR

Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clover Pharms
aminocaproic acid
INJECTABLE;INJECTION015229-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Clover Pharms
aminocaproic acid
TABLET;ORAL015197-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Clover Pharms
aminocaproic acid
SYRUP;ORAL015230-002Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
Clover Pharms
aminocaproic acid
TABLET;ORAL015197-002Jun 24, 2004RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus